576
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Effects of spray drying process parameters on the solubility behavior and physical stability of solid dispersions prepared using a laboratory-scale spray dryer

, , , , &
Pages 1484-1493 | Received 06 Feb 2012, Accepted 05 May 2012, Published online: 07 Jun 2012

References

  • Lipinsky C. (2002). Poor aqueous solubility - an industry wide problem in drug discovery. Am Pharm Rev, 5: 82–85.
  • Takano R, Furumoto K, Shiraki K, Takata N, Hayashi Y, Aso Y et al. (2008). Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation. Pharm Res, 25:2334–2344.
  • Kennedy M, Hu J, Gao P, Li L, Ali-Reynolds A, Chal B et al. (2008). Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study. Mol Pharm, 5:981–993.
  • Chokshi RJ, Zia H, Sandhu HK, Shah NH, Malick WA. (2007). Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons. Drug Deliv, 14:33–45.
  • Bak A, Gore A, Yanez E, Stanton M, Tufekcic S, Syed R et al. (2008). The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. J Pharm Sci, 97:3942–3956.
  • Shiraki K, Takata N, Takano R, Hayashi Y, Terada K. (2008). Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds. Pharm Res, 25:2581–2592.
  • Sakai K, Maeda H, Yoshimori T, Obata K, Ogawa Y. (2009). High-throughput formulation screening system for self-microemulsifying drug delivery. Drug Dev Ind Pharm, 35:746–755.
  • Hancock BC, Zografi G. (1997). Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci, 86:1–12.
  • Hancock BC, Shamblin SL, Zografi G. (1995). Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res, 12:799–806.
  • Hancock BC, Shalaev EY, Shamblin SL. (2002). Polyamorphism: a pharmaceutical science perspective. J Pharm Pharmacol, 54:1151–1152.
  • Serajuddin AT. (1999). Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci, 88:1058–1066.
  • Chokshi RJ, Sandhu HK, Iyer RM, Shah NH, Malick AW, Zia H. (2005). Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution. J Pharm Sci, 94:2463–2474.
  • El-Gazayerly ON. (2000). Characterization and evaluation of tenoxicam coprecipitates. Drug Dev Ind Pharm, 26: 925–930.
  • Thybo P, Pedersen BL, Hovgaard L, Holm R, Mullertz A. (2008). Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30. Pharm Dev Technol, 13:375–386.
  • Janssens S, De Zeure A, Paudel A, Van Humbeeck J, Rombaut P, Van den Mooter G. (2010). Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit e100. Pharm Res, 27:775–785.
  • Okimoto K, Miyake M, Ibuki R, Yasumura M, Ohnishi N, Nakai T. Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose. Int J Pharm, 1997; 159: 85–93.
  • Hirasawa N, Ishise S, Miyata H, Danjo K. (2003). Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier. Drug Dev Ind Pharm, 29:339–344.
  • Cilurzo F, Minghetti P, Casiraghi A, Montanari L. (2002). Characterization of nifedipine solid dispersions. Int J Pharm, 242:313–317.
  • Geppi M, Guccione S, Mollica G, Pignatello R, Veracini CA. (2005). Molecular properties of ibuprofen and its solid dispersions with Eudragit RL100 studied by solid-state nuclear magnetic resonance. Pharm Res, 22:1544–1555.
  • Aso Y, Yoshioka S. (2006). Molecular mobility of nifedipine-PVP and phenobarbital-PVP solid dispersions as measured by 13C-NMR spin-lattice relaxation time. J Pharm Sci, 95:318–325.
  • Matsumoto T, Zografi G. (1999). Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res, 16:1722–1728.
  • Forster A, Hempenstall J, Rades T. (2001). Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J Pharm Pharmacol, 53:303–315.
  • Taylor LS, Zografi G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res, 14:1691–1698.
  • Taylor LS, Langkilde FW, Zografi G. (2001). Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers. J Pharm Sci, 90:888–901.
  • Zhang J, Bunker M, Chen X, Parker AP, Patel N, Roberts CJ. (2009). Nanoscale thermal analysis of pharmaceutical solid dispersions. Int J Pharm, 380:170–173.
  • Gander B, Wehrli E, Alder R, Merkle HP. (1995). Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. J Microencapsul, 12:83–97.
  • Iskandar F, Gradon L, Okuyama K. (2003). Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol. J Colloid Interface Sci, 265:296–303.
  • Sen D, Spalla O, Taché O, Haltebourg P, Thill A. (2007). Slow drying of a spray of nanoparticles dispersion. In situ SAXS investigation. Langmuir, 23:4296–4302.
  • He X, Pei L, Tong HH, Zheng Y. (2011). Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability. AAPS PharmSciTech, 12:104–113.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.